Cytotoxicity Study Using the USP Elution Method

The USP Elution Method is a widely used in vitro cytotoxicity test designed to evaluate the biological safety of medical devices. It determines whether materials or their extracts cause toxic effects on cultured cells, such as cell death or inhibited growth. By exposing cells to eluates—solutions extracted from device materials—this method helps identify potential biocompatibility concerns early in development. It serves as a critical screening tool for regulatory submissions and product safety validation, especially for devices that come into direct or indirect contact with human tissue.

Why This Testing is Performed

Cytotoxicity testing is essential to ensure that medical devices do not release harmful substances that could damage or kill cells. It helps manufacturers detect risks early and confirm that their products meet safety requirements for human use. The USP Elution Method is particularly effective for identifying leachable substances that may not be detected through other biocompatibility tests.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Sample Preparation: Device materials are prepared for extraction.
2. Extraction: Materials are immersed in a solvent to produce eluates.
3. Cell Culture: Cells such as fibroblasts are cultured in a controlled environment.
4. Eluate Exposure: Cultured cells are exposed to the eluates for 24–48 hours.
5. Evaluation: Cell viability, morphology, and proliferation are assessed microscopically.
6. Interpretation: Cytotoxicity is graded based on observed cellular responses.

Standards, Guidance, and Regulations

• USP <87>: Specifies procedures for in vitro biological reactivity tests, including the agar diffusion method.
• ISO 10993-5: Outlines procedures for in vitro cytotoxicity testing, including the USP Elution Method.
• FDA Guidance: Aligns with ISO 10993-1 for biological evaluation within a risk management framework.
• GLP Compliance: Testing must follow FDA Good Laboratory Practice regulations (21 CFR Part 58) for regulatory acceptance.